AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Archives: News
Innoplexus: Big Steps to Combat the Coronavirus
ESCHBORN, Germany, March 18, 2020 /PRNewswire/ — The German company Innoplexus AG, also known as the “Google of the healthcare industry” (Welt) – is taking further steps to combat the coronavirus. In recent days, there has been a global paradigm shift in the handling of the coronavirus. A drastic change in political measures is taking place …
Innoplexus Opens Its Ontosight® AI Search Platform to COVID-19 Research
FRANKFURT, Germany, March 15, 2020,/PRNewswire/ — Innoplexus AG has made its proprietary Ontosight® AI search platform available to medical researchers around the globe to help fight the COVID-19 pandemic with immediate effect. The platform is already being used by researchers from Germany, USA, and India. ‘Flattening the curve’ necessitates health organizations to take on early measures …
Innoplexus Opens Its Ontosight® AI Search Platform to COVID-19 Research Read More »
Innoplexus AG announces the appointment of Christian Bigatà Joseph as Chief Financial Officer (CFO) and Dr. Katharina Schreeb as Chief Medical Officer (CMO)
Eschborn, 11.03.2020 – The Supervisory Board of Innoplexus AG has appointed Christian Bigatà Joseph (45) as CFO, effective as of February 1, 2020. Christian has more than 20 years of Finance expertise, the largest part spent in management positions in Tech and Data companies. Amongst other mandates, he has served as CFO and Member of the …
Innoplexus Consulting Services is Proud to Announce ISO/IEC 27001:2013 Certification
Pune, India, February 13, 2020 – Innoplexus Consulting Services Private Limited, a subsidiary of Innoplexus AG, is delighted to have been awarded ISO/IEC 27001:2013 certification, a global standard for reducing the risk and improving the security of data. Innoplexus has been committed to achieving the highest levels of security compliance. This accreditation further cements Innoplexus’ …
Innoplexus Consulting Services is Proud to Announce ISO/IEC 27001:2013 Certification Read More »
Catana Capital: New collaboration with Life Science AI pioneer Innoplexus
Catana Capital partners with a leading provider of AI solutions in the Life Science sector Frankfurt am Main, December 16, 2019: As a pioneer in the application of Big Data and AI for quantitative asset management, Catana Capital is always open to collaborate with other innovators in the space in order to develop new innovative investment …
Catana Capital: New collaboration with Life Science AI pioneer Innoplexus Read More »
Innoplexus and Wiley partner to provide AI-powered solutions over comprehensive research literature
Frankfurt, Germany, October 15, 2019 – Innoplexus AG announces a partnership with John Wiley & Sons, Inc. (NYSE: JW-A) (NYSE: JW-B) to enable Innoplexus’s proprietary, ontology-driven search and artificial intelligence-powered analysis on the full text of life science articles published by Wiley, one of the largest scientific and scholarly publishing houses in the world. This …
Innoplexus and ChemAxon partner to get more out of life science data
Frankfurt, Germany – Budapest, Hungary, September 16, 2019 – Innoplexus announces an official partnership with ChemAxon, getting the most value out from life sciences data. Through the joint venture, Innoplexus will enable big pharma and biotech companies to find and connect information about pharmaceutical compounds from publicly available, or archived enterprise datasets to generate novel …
Innoplexus and ChemAxon partner to get more out of life science data Read More »
Innoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President
Hoboken, New Jersey, September 16, 2019- Innoplexus Inc., a subsidiary of Innoplexus AG, announced today the appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President. Mr. Davlos is a highly accomplished artificial intelligence and machine learning executive with over 20 years of leadership experience. Prior to joining Innoplexus, Mr. Davlos was …
Traum aller Anleger
Innoplexus aus Eschborn und der Vermögensverwalter Acatis aus Frankfurt testen eine neue KI-Maschine für die Geldanlage. Der 21. März 2019 bleibt den Aktionären des Pharmakonzerns Biogen in schmerzhafter Erinnerung. Kurz vor Börsenbeginn hatte der in Cambridge, Massachusetts, aufgehende Stern am Biotech-Himmel die Investoren darüber unterrichtet, dass er eine klinische Studie mit seinem Alzheimer-Präparat „Aducanumab“ abbrechen …